Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Protara Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +2 vs. Q2 2023
- Shares held
- 5.12M
- −18.9K (−0.4%) vs. Q2 2023
- Total value
- $8.55M
- −$3.71M (−30.3%) vs. Q2 2023
- New holders
- 4
- 3 more added
- Sold out
- 2
- 9 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 2 | $3 | 0.00% | +2 | New |
| JPMorgan Chase & Co | 11 | $18 | 0.00% | +11 | New |
| Advisor Group Holdings, Inc. | 100 | $167 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 121 | $202 | 0.00% | +121 | New |
| Wells Fargo & Company | 565 | $944 | 0.00% | +2+0.4% | Added |
| Royal Bank of Canada | 500 | $1.00K | 0.00% | −2,920−85.4% | Reduced |
| Tower Research Capital LLC (TRC) | 4,794 | $8.01K | 0.00% | +2,583+116.8% | Added |
| Acadian Asset Management LLC | 6,314 | $10.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 10,000 | $16.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 13,821 | $23.1K | 0.00% | −4,931−26.3% | Reduced |
| Assenagon Asset Management S.A. | 15,831 | $26.4K | 0.00% | −13,220−45.5% | Reduced |
| Bank of New York Mellon Corp | 17,907 | $29.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 18,047 | $30.1K | 0.00% | −6,501−26.5% | Reduced |
| Boothbay Fund Management, LLC | 18,864 | $31.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 20,587 | $34.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,143 | $37.0K | 0.00% | +12,135+121.3% | Added |
| Two Sigma Investments, LP | 27,345 | $45.7K | 0.00% | −7,400−21.3% | Reduced |
| Two Sigma Advisers, LP | 27,818 | $46.5K | 0.00% | −3,500−11.2% | Reduced |
| State Street Corp | 30,900 | $51.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 34,602 | $57.8K | 0.00% | −1,636−4.5% | Reduced |
| Susquehanna International Group, LLP | 34,971 | $58.4K | 0.00% | +34,971 | New |
| Renaissance Technologies LLC | 60,100 | $100.0K | 0.00% | −23,500−28.1% | Reduced |
| Bridgeway Capital Management, LLC | 64,000 | $106.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 78,518 | $131.2K | 0.00% | −4,902−5.9% | Reduced |
| Privium Fund Management (UK) Ltd | 119,730 | $201.1K | 0.16% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 188,664 | $315.1K | 0.12% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $333.5K | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $349.4K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 427,612 | $714.1K | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 772,584 | $1.29M | 0.03% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,692,594 | $4.50M | 1.48% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −195−100.0% | Sold out |